MicroRNA-144 mediates metabolic shift in ovarian cancer cells by directly targeting Glut1
- PMID: 26662316
- DOI: 10.1007/s13277-015-4558-9
MicroRNA-144 mediates metabolic shift in ovarian cancer cells by directly targeting Glut1
Retraction in
-
Retraction Note to multiple articles in Tumor Biology.Tumour Biol. 2017 Apr 20. doi: 10.1007/s13277-017-5487-6. Online ahead of print. Tumour Biol. 2017. PMID: 28792236 No abstract available.
Abstract
Warburg effect is characterized by an increased utilization of glucose via glycolysis in cancer cells, even when enough oxygen is present to properly respire. Recent studies demonstrate that deregulation of microRNAs contributes to the Warburg effect. In the present study, we show that miR-144 is downregulated while glucose transporter 1 (Glut1) is upregulated in ovarian cancers. In vitro studies further showed that miR-144 inhibits Glut1 expression through targeting its 3'-untranslated region. As a result, cells overexpressing miR-144 exhibited a metabolic shift, including enhanced glucose uptake and lactate production. The altered glucose metabolism induced by miR-144 also leads to a rapid growth of ovarian cancer cells. Taken together, our results indicate that miR-144 may serve as a molecular switch to regulate glycolysis in ovarian cancer by targeting the expression of Glut1.
Keywords: Glut1; MicroRNA-144; Ovarian cancer; Warburg effect.
Similar articles
-
miR-495 mediates metabolic shift in glioma cells via targeting Glut1.J Craniofac Surg. 2015 Mar;26(2):e155-8. doi: 10.1097/SCS.0000000000001385. J Craniofac Surg. 2015. PMID: 25759932
-
FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription.Oncotarget. 2016 Jul 26;7(30):47985-47997. doi: 10.18632/oncotarget.10103. Oncotarget. 2016. PMID: 27351131 Free PMC article.
-
Circle RNA hsa_circRNA_100290 serves as a ceRNA for miR-378a to regulate oral squamous cell carcinoma cells growth via Glucose transporter-1 (GLUT1) and glycolysis.J Cell Physiol. 2019 Nov;234(11):19130-19140. doi: 10.1002/jcp.28692. Epub 2019 Jun 11. J Cell Physiol. 2019. PMID: 31187488
-
The progress and development of GLUT1 inhibitors targeting cancer energy metabolism.Future Med Chem. 2019 Sep;11(17):2333-2352. doi: 10.4155/fmc-2019-0052. Future Med Chem. 2019. PMID: 31581916 Review.
-
CircRNA-regulated glucose metabolism in ovarian cancer: an emerging landscape for therapeutic intervention.Clin Transl Oncol. 2024 Mar;26(3):584-596. doi: 10.1007/s12094-023-03285-4. Epub 2023 Aug 14. Clin Transl Oncol. 2024. PMID: 37578652 Review.
Cited by
-
Dichloroacetate and metformin synergistically suppress the growth of ovarian cancer cells.Oncotarget. 2016 Sep 13;7(37):59458-59470. doi: 10.18632/oncotarget.10694. Oncotarget. 2016. PMID: 27449090 Free PMC article.
-
Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence.Metabolites. 2023 Apr 15;13(4):560. doi: 10.3390/metabo13040560. Metabolites. 2023. PMID: 37110218 Free PMC article. Review.
-
MiR-144 inhibits cell proliferation of renal cell carcinoma by targeting MTOR.J Huazhong Univ Sci Technolog Med Sci. 2016 Apr;36(2):186-192. doi: 10.1007/s11596-016-1564-0. Epub 2016 Apr 13. J Huazhong Univ Sci Technolog Med Sci. 2016. PMID: 27072960
-
MiR-144-3p inhibits cell proliferation and induces apoptosis in multiple myeloma by targeting c-Met.Am J Transl Res. 2017 May 15;9(5):2437-2446. eCollection 2017. Am J Transl Res. 2017. PMID: 28559994 Free PMC article.
-
The sweet trap in tumors: aerobic glycolysis and potential targets for therapy.Oncotarget. 2016 Jun 21;7(25):38908-38926. doi: 10.18632/oncotarget.7676. Oncotarget. 2016. PMID: 26918353 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous